Osteosarcoma is an uncommon
tumor occurring in bone, accompanied by elevated incidence and reduced rate of healing. Epithelial-to-mesenchymal transition (EMT) serves as a conceptual paradigm to explain the invasion and
metastasis of
osteosarcoma and other
cancers. Hence, developing effective therapeutic strategy to treat the EMT of
osteosarcoma is essential. Here, we identified the molecular mechanism of
long noncoding RNA (
lncRNA) PGM5-AS1 in EMT and progression of
osteosarcoma. Microarray-based analysis was employed to screen the
osteosarcoma-related differentially expressed lncRNAs. The levels of PGM5-AS1 as well as microRNA-140-5p (miR-140-5p) and
fibrillin-1 (FBN1) in
osteosarcoma tissues and cells were determined. Dual-
luciferase reporter gene assay,
RNA pull-down assay, and
RNA immunoprecipitation assay were conducted to validate the relationship among PGM5-AS1, miR-140-5p, and FBN1. Expression of PGM5-AS1, miR-140-5p, and FBN1 was altered by overexpression,
shRNA, mimic, or inhibitors in order to investigate how they regulated migration, invasion, and EMT of
osteosarcoma cells in vitro. Loss- and gain-of-function approaches were employed in nude mice to detect their roles in
tumorigenesis in vivo.
Osteosarcoma tissues and cells exhibited low expression of miR-140-5p, but high expression of PGM5-AS1 and FBN1. PGM5-AS1 competitively bound to miR-140-5p to upregulate FBN1. Furthermore, hindering PGM5-AS1 and FBN1 or overexpressing miR-140-5p dampened migration, invasion, and EMT of
osteosarcoma cells in vitro. Furthermore, silencing PGM5-AS1 or FBN1, or overexpressing miR-140-5p markedly inhibited
tumorigenesis in nude mice in vivo. Taken together, PGM5-AS1 depletion causes FBN1 reduction to retard
osteosarcoma processes by negatively modulating miR-140-5p.